Muscoloskeletal aging, sarcopenia and cancer

Giuseppe Colloca, Beatrice Di Capua, Andrea Bellieni, Matteo Cesari, Vincenzo Valentini, Emanuele Marzetti, Riccardo Calvani

Research output: Contribution to journalArticle

Abstract

In the context of the management of the elderly patient with cancer, currently, a key topic may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in the older adult is always related to negative outcomes. A close correlation between sarcopenia and adverse outcomes such as treatment response or toxicity has also been shown in the patient with cancer. For these reasons, it becomes increasingly important to try to understand and therefore differentiate conditions such as the loss of muscle mass linked to normal aging, an independent pathological condition such as sarcopenia and finally a sometimes confusing pathologic condition called cachexia.

Original languageEnglish
JournalJournal of Geriatric Oncology
DOIs
Publication statusE-pub ahead of print - Dec 11 2018

Fingerprint

Sarcopenia
Neoplasms
Cachexia
Muscles

Cite this

Muscoloskeletal aging, sarcopenia and cancer. / Colloca, Giuseppe; Di Capua, Beatrice; Bellieni, Andrea; Cesari, Matteo; Valentini, Vincenzo; Marzetti, Emanuele; Calvani, Riccardo.

In: Journal of Geriatric Oncology, 11.12.2018.

Research output: Contribution to journalArticle

Colloca, Giuseppe ; Di Capua, Beatrice ; Bellieni, Andrea ; Cesari, Matteo ; Valentini, Vincenzo ; Marzetti, Emanuele ; Calvani, Riccardo. / Muscoloskeletal aging, sarcopenia and cancer. In: Journal of Geriatric Oncology. 2018.
@article{0d4d136066234f7dbb0a6e5621ea3c1f,
title = "Muscoloskeletal aging, sarcopenia and cancer",
abstract = "In the context of the management of the elderly patient with cancer, currently, a key topic may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in the older adult is always related to negative outcomes. A close correlation between sarcopenia and adverse outcomes such as treatment response or toxicity has also been shown in the patient with cancer. For these reasons, it becomes increasingly important to try to understand and therefore differentiate conditions such as the loss of muscle mass linked to normal aging, an independent pathological condition such as sarcopenia and finally a sometimes confusing pathologic condition called cachexia.",
author = "Giuseppe Colloca and {Di Capua}, Beatrice and Andrea Bellieni and Matteo Cesari and Vincenzo Valentini and Emanuele Marzetti and Riccardo Calvani",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = "12",
day = "11",
doi = "10.1016/j.jgo.2018.11.007",
language = "English",
journal = "Journal of Geriatric Oncology",
issn = "1879-4068",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Muscoloskeletal aging, sarcopenia and cancer

AU - Colloca, Giuseppe

AU - Di Capua, Beatrice

AU - Bellieni, Andrea

AU - Cesari, Matteo

AU - Valentini, Vincenzo

AU - Marzetti, Emanuele

AU - Calvani, Riccardo

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/12/11

Y1 - 2018/12/11

N2 - In the context of the management of the elderly patient with cancer, currently, a key topic may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in the older adult is always related to negative outcomes. A close correlation between sarcopenia and adverse outcomes such as treatment response or toxicity has also been shown in the patient with cancer. For these reasons, it becomes increasingly important to try to understand and therefore differentiate conditions such as the loss of muscle mass linked to normal aging, an independent pathological condition such as sarcopenia and finally a sometimes confusing pathologic condition called cachexia.

AB - In the context of the management of the elderly patient with cancer, currently, a key topic may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in the older adult is always related to negative outcomes. A close correlation between sarcopenia and adverse outcomes such as treatment response or toxicity has also been shown in the patient with cancer. For these reasons, it becomes increasingly important to try to understand and therefore differentiate conditions such as the loss of muscle mass linked to normal aging, an independent pathological condition such as sarcopenia and finally a sometimes confusing pathologic condition called cachexia.

U2 - 10.1016/j.jgo.2018.11.007

DO - 10.1016/j.jgo.2018.11.007

M3 - Article

C2 - 30551959

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

SN - 1879-4068

ER -